期刊文献+

ALTERATION OF HB-EGF IN PSORIATIC EPIDERMIS WITH THE TREATMENT OF RETINOID ACID 被引量:2

ALTERATION OF HB-EGF IN PSORIATIC EPIDERMIS WITH THE TREATMENT OF RETINOID ACID
下载PDF
导出
摘要 Objective To investigate the mechanism of tazarotene in active psoriasis vulgaris. Methods HB EGF protein in active psoriatic lesions before and 10 days after the treatment of tazarotene was detected by immunohistochemistry. Results There was nearly no expression of HB EGF in psoriatic lesions (9.1%), but after the treatment by tazarotene, there was expression of HB EGF not only in basal layer (95.5%), but also focal expression in suprabasal layers of epidermis (77.3%) . Conclusion Tazarotene inhibit proliferation and induce apoptosis of keratinocytes through upregulating expression of HB EGF in psoriatic epidermis. Objective To investigate the mechanism of tazarotene in active psoriasis vulgaris. Methods HB EGF protein in active psoriatic lesions before and 10 days after the treatment of tazarotene was detected by immunohistochemistry. Results There was nearly no expression of HB EGF in psoriatic lesions (9.1%), but after the treatment by tazarotene, there was expression of HB EGF not only in basal layer (95.5%), but also focal expression in suprabasal layers of epidermis (77.3%) . Conclusion Tazarotene inhibit proliferation and induce apoptosis of keratinocytes through upregulating expression of HB EGF in psoriatic epidermis.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2003年第1期41-43,共3页 药物分析学报(英文版)
基金 ThisworkwassupportedbytheNationalNaturalScienceFoundationofChina (No .3 0 0 70 699)
关键词 PSORIASIS HB EGF suprabasal epidermis psoriasis HB EGF suprabasal epidermis
  • 相关文献

同被引文献3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部